Targeted therapies are a type of medicine used to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted ...

Colon cancers are especially tough to treat in their advanced stages A new trial finds the use of two immunotherapy drugs plus standard chemo nearly doubled survival times in patients with these ...

While there are several treatment options for colon cancer, not all of them work for all cancer types. Deficient mismatch repair (dMMR) colon cancer is known to be less responsive to chemotherapy than ...

Colorectal cancer often spreads to the liver, requiring prolonged chemotherapy. But now, doctors are turning to hepatic artery infusion. This therapy delivers chemo directly into the liver, and that, ...

People battling advanced colon cancers might have a new treatment option that could extend their survival, a new trial finds. A combination of two experimental immunotherapy drugs plus standard ...

Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy A significant overall survival (OS) benefit of ...

An interview with Dr. Nancy Baxter on "Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline." The guideline makes recommendations based on ...

In this global network study, researchers examined vitamin B12 levels as a possible biomarker for outcomes in colon cancer.